Skip to main content

Table 1 Clinical characteristic of HCC patients and cancer-free controls

From: Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6

Features

Cases (n = 64)

Controls (n = 30)

P*

P #

N

%

N

%

Age (years)

    

0.805

0.743

 ≤ 50

36

56.25

16

53.33

  

 > 50

28

43.75

14

46.67

  

Gender

    

0.248

0.321

 Male

42

65.63

15

50.00

  

 Female

22

34.38

15

50.00

  

HBV infection

    

< 0.0001

0.145

 Positive

58

90.63

5

16.67

  

 Negative

6

9.38

25

83.33

  

TMN stage

     

0.012

 I

12

18.75

    

 II

22

34.38

    

 III

17

26.56

    

 IV

13

20.31

    

Tumor size (cm)

     

0.004

 ≤ 5

37

57.81

    

 > 5

27

42.19

    

Metastasis

     

0.143

 Yes

27

42.19

    

 No

37

57.81

    
  1. * Two-sided Chi square test for different features between cases and controls
  2. # The student’s t-test for circ-ZEB1.33 expression among different features of HCC patients
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us